BioPharma Credit PLC Holding(s) in Company (3359C)
12 April 2017 - 8:24PM
UK Regulatory
TIDMBPCR
RNS Number : 3359C
BioPharma Credit PLC
12 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
-----------------------------------------------
1. Identity of the issuer or the underlying BioPharma Credit PLC
issuer
of existing shares to which voting rights
are
attached:
------------------------------------------------------------------------- --------------------------
2. Reason for the notification (please tick the appropriate box or boxes):
-----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------------------------------------- ----
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------------------------- ----
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
----------------------------------------------------------------------------------------------- ----
An event changing the breakdown of voting rights
----------------------------------------------------------------------------------------------- ----
Other (please Issue of New Shares Yes
specify):
------------------------------------------------------------------------ --------------------- ----
3. Full name of person(s) subject Phemus Corporation
to the
notification obligation:
------------------------------------------------------------------------- --------------------------
4. Full name of shareholder(s)
(if different from 3.):
------------------------------------------------------------------------- --------------------------
5. Date of the transaction and date 27 March 2017
on
which the threshold is crossed
or
reached:
------------------------------------------------------------------------- --------------------------
6. Date on which issuer notified: 12 April 2017
------------------------------------------------------------------------- --------------------------
7. Threshold(s) that is/are crossed
or
reached: 4%
------------------------------------------------------------------------- --------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
-----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ----------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights
Shares Voting
Rights
------------- --------------- --------------- ------------- -------------------------- ---------------------------
Direct/ Direct Indirect Direct Indirect
Indirect
------------- ----------- ----------- ------------- ------------- ----------- ------------ -------------
ORD USD0.01 Below 5% Below 5% 32,688,075 32,688,075 4.3%
--------------- --------------- ------------- ------------- ----------- ------------ -------------
GB00BDGKMY29
------------- ----------- ----------- ----------- ----------- ----------- -------- -----------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion Period rights that may rights
instrument be
acquired if the
instrument is
exercised/ converted.
----------------- ------------- ------------------------------ ---------------------------- -----------------------
N/A N/A N/A N/A N/A
----------------- ------------- ------------------------------ ---------------------------- -----------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
-----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date Conversion rights instrument
instrument period refers to
--------------- ------------- ------------- --------------- ---------------------------- -------------------------
N/A N/A N/A N/A N/A Nominal Delta
--------------- ------------- ------------- --------------- ---------------------------- ------------ -----------
N/A N/A
------------- ----------- ----------- ----------- ----------- ----------- ------------ -----------
Total (A+B+C)
-----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- --------------------------------------------------------------------
32,688,075 4.3%
------------------------------------------------- --------------------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable:
----------------------------------------------------------------------------------------------
Proxy Voting:
----------------------------------------------------------------------------------------------
10. Name of the proxy holder:
---------------------------------------------------------------------------- ----------------
11. Number of voting rights proxy holder will
cease
to hold:
---------------------------------------------------------------------------- ----------------
12. Date on which proxy holder will cease to
hold
voting rights:
---------------------------------------------------------------------------- ----------------
13. Additional information:
---------------------------------------------------------------------------- ----------------
14. Contact name: Sean C.Rogers
---------------------------------------------------------------------------- ----------------
15. Contact telephone number: +1-617-720-6561
---------------------------------------------------------------------------- ----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUURRBRASAAR
(END) Dow Jones Newswires
April 12, 2017 06:24 ET (10:24 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024